O'Shaughnessy Asset Management’s BridgeBio Pharma BBIO Stock Holding History

O'Shaughnessy Asset Management’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$932K	Buy	12,511 +1,171	+10%	+$82K	﹤0.01%	1290
2026 Q1	$842K	Sell	11,340 -3,337	-23%	-$242K	﹤0.01%	1271
2025 Q4	$1.12M	Buy	14,677 +2,025	+16%	+$133K	0.01%	1089
2025 Q3	$657K	Buy	12,652 +7,886	+165%	+$385K	﹤0.01%	1346
2025 Q2	$206K	Buy	+4,766	New	+$173K	﹤0.01%	1820
2021 Q4	–	Sell	-3,829	Closed	-$180K	–	1365
2021 Q3	$180K	Sell	3,829 -683	-15%	-$36.6K	﹤0.01%	1094
2021 Q2	$275K	Hold	4,512	–	–	0.01%	888
2021 Q1	$278K	Buy	+4,512	New	+$295K	0.01%	798

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

O'Shaughnessy Asset Management's BBIO Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its BridgeBio Pharma (BBIO) stake by 10% in Q2 2026, buying an estimated $82K and bringing the position to 12,511 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

O'Shaughnessy Asset Management first reported a position in BBIO in Q1 2021 and has held it in 8 quarters since. The position peaked at $1.12M in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

O'Shaughnessy Asset Management held 12,511 shares of BridgeBio Pharma worth $932K as of Q2 2026.
O'Shaughnessy Asset Management bought 1,171 BridgeBio Pharma shares in Q2 2026, an estimated $82K.
BridgeBio Pharma made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1290 holding.
O'Shaughnessy Asset Management first reported a position in BridgeBio Pharma in Q1 2021 and has held it in 8 quarters since.
O'Shaughnessy Asset Management's BridgeBio Pharma position peaked at $1.12M in Q4 2025.
474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.